Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease

Stroke

Volumn 35, Issue 12, 2004, Pages 2837-2842

  Nanba, Rina ^a   Kuroda, Satoshi ^a   Ishikawa, Tatsuya ^a   Houkin, Kiyohiro ^a   Iwasaki, Yoshinobu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Hepatocyte growth factor; Moyamoya disease; Protooncogene protein c met

Indexed keywords

ANGIOGENIC FACTOR; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; CEREBRAL ARTERY DISEASE; CEREBROSPINAL FLUID LEVEL; CERVICAL SPONDYLOSIS; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INTERNAL CAROTID ARTERY OCCLUSION; INTIMA; MALE; MOYAMOYA DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; CAROTID ARTERIES; CEREBRAL ARTERIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; MOYAMOYA DISEASE; PROTO-ONCOGENE PROTEINS C-MET; TUNICA INTIMA;

EID: 9444274816     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000148237.13659.e6     Document Type: Article

References (28)

1. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288-299.
2. Fukui M, Kono S, Sueishi K, Ikezaki K. Moyamoya disease. Neuropathology. 2000;20(supp 1):S61-S64.
3. Ikeda E. Systemic vascular changes in spontaneous occlusion of the circle of Willis. Stroke. 1991;22:1358-1362.
4. Yamada H, Deguchi K, Tanigawara T, Takenaka K, Nishimura Y, Shinoda J, Hattori T, Andoh T, Sakai N. The relationship between moyamoya disease and bacterial infection. Clin Neurol Neurosurg. 1997;99(suppl 2):S221-S224.
5. Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, Abe H, Inoue T, Ikezaki K, Matsushima T, Fukui M. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000;31:930-935.
6. Goto Y, Yonekawa Y. Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo). 1992;32:883-886.
7. Hoshimaru M, Takahashi JA, Kikuchi H, Nagata I, Hatanaka M. Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study. J Neurosurg. 1991;75:267-270.
8. Malek AM, Connors S, Robertson RL, Folkman J, Scott RM. Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders. Pediatr Neurosurg. 1997;27:182-189.
9. Houkin K, Yoshimoto T, Abe H, Nagashima K, Nagashima M, Takeda M, Isu T. Role of basic fibroblast growth factor in the pathogenesis of moyamoya disease. Neurosurg Focus. 1998;5:1-5.
10. Takahashi A, Sawamura Y, Houkin K, Kamiyama H, Abe H. The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor. Neurosci Lett. 1993;160:214-216.
11. Yoshimoto T, Houkin K, Takahashi A, Abe H. Angiogenic factors in moyamoya disease. Stroke. 1996;27:2160-2165.
12. Soriano SG, Cowan DB, Proctor MR, Scott RM. Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome. Neurosurgery. 2002;50:544-549.
13. Kim SK, Yoo JI, Cho BK, Hong SJ, Kim YK, Moon JA, Kim JH, Chung YN, Wang KC. Elevation of CRABP-I in the cerebrospinal fluid of patients with moyamoya disease. Stroke. 2003;34:2835-2841.
14. Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Matsumoto K, et al. Expression of local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun. 1995;215:483-488.
15. Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michalopoulos GK, Comoglio PM. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-Met. Oncogene. 1991;6:501-504.
16. Nishimura M, Ushiyama M, Nanbu A, Ohtsuka K, Takahashi H, Yoshimura M. Serum hepatocyte growth factor as a possible indicator of arteriosclerosis. J Hypertens. 1997;15:1137-1142.
17. Nakamura Y, Morishita R, Nakamura S, Aoki M, Moriguchi A, Matsumoto K, Nakamura T, Higaki J, Ogihara T. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension. 1996;28:409-413.
18. Morishita R, Sakaki M, Yamamoto K, Iguchi S, Aoki M, Yamasaki K, Matsumoto K, Nakamura T, Lawn R, Ogihara T, Kaneda Y. Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene. Circulation. 2002;105:1491-1496.
19. Morishita R, Aoki M, Nakamura S, Higaki J, Kaneda Y, Ogihara T. Gene therapy for cardiovascular disease using hepatocyte growth factor. Ann N Y Acad Sci. 2000;902:369-376.
20. Hayashi S, Morishita R, Higaki J, Aoki M, Moriguchi A, Kida I, Yoshiki S, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T. Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. Biochem Biophys Res Commun. 1996;220:539-545.
21. Taher TE, Derksen PW, de Boer OJ, Spaargaren M, Teeling P, van der Wal AC, Pals ST. Hepatocyte growth factor triggers signaling cascades mediating vascular smooth muscle cell migration. Biochem Biophys Res Commun. 2002;298:80-86.
22. Hayashi T, Abe K, Sakurai M, Itoyama Y. Inductions of hepatocyte growth factor and its activator in rat brain with permanent middle cerebral artery occlusion. Brain Res. 1998;799:311-316.
23. Nagayama T, Nagayama M, Kohara S, Kamiguchi H, Shibuya M, Katoh Y, Itoh J, Shinohara Y. Post-ischemic delayed expression of hepatocyte growth factor and c-Met in mouse brain following focal cerebral ischemia. Brain Res. 2004;999:155-166.
24. Tsuzuki N, Miyazawa T, Matsumoto K, Nakamura T, Shima K. Hepatocyte growth factor reduces the infarct volume after transient focal cerebral ischemia in rats. Neurol Res. 2001;23:417-424.
25. Shimamura M, Sato N, Oshima K, Aoki M, Kurinami H, Waguri S, Uchiyama Y, Ogihara T, Kaneda Y, Morishita R. Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model. Circulation. 2004;109:424-431.
26. Nayeri F, Nilsson I, Hagberg L, Brudin L, Roberg M, Soderstrom C, Forsberg P. Hepatocyte growth factor levels in cerebrospinal fluid: a comparison between acute bacterial and nonbacterial meningitis. J Infect Dis. 2000;181:2092-2094.
27. Kern MA, Bamborschke S, Nekic M, Schubert D, Rydin C, Lindholm D, Schirmacher P. Concentrations of hepatocyte growth factor in cerebrospinal fluid under normal and different pathological conditions. Cytokine. 2001;14:170-176.
28. Tsuboi Y, Kakimoto K, Nakajima M, Akatsu H, Yamamoto T, Ogawa K, Ohnishi T, Daikuhara Y, Yamada T. Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease. Acta Neurol Scand. 2003;107:81-86.